Andrea Marchetti

Via Albertoni-15
Bologna, 40138, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Advancements of investigational agents for renal cell carcinoma: what clinical progress have we seen in the last 5 years?

Advancements of investigational agents for renal cell carcinoma: what clinical progress have we seen in the last 5 years?

Journal: Expert opinion on investigational drugs

Published: December 19, 2025

Re: First-line Therapy for Advanced Non-Clear Cell Renal Cell Carcinoma. A Systematic Review and Meta-analysis.

Re: First-line Therapy for Advanced Non-Clear Cell Renal Cell Carcinoma. A Systematic Review and Meta-analysis.

Journal: European urology

Published: July 13, 2025

Immunohistochemical expression of Nectin-4 and potential implications for enfortumab vedotin therapy in germ cell tumors of the testis: a preliminary study.

Immunohistochemical expression of Nectin-4 and potential implications for enfortumab vedotin therapy in germ cell tumors of the testis: a preliminary study.

Journal: Virchows Archiv : an international journal of pathology

Published: June 19, 2025

Pathological and Clinical Implications of Tumor Microenvironment Evaluated With Multiplex Immunohistochemistry in Testicular Embryonal Carcinoma.

Pathological and Clinical Implications of Tumor Microenvironment Evaluated With Multiplex Immunohistochemistry in Testicular Embryonal Carcinoma.

Journal: Clinical genitourinary cancer

Published: June 05, 2025

Immunohistochemical expression of EZH2 in germ cell tumors of the testis: New insights into the genesis and epigenetic reprogramming of these fascinating tumors.

Immunohistochemical expression of EZH2 in germ cell tumors of the testis: New insights into the genesis and epigenetic reprogramming of these fascinating tumors.

Journal: American journal of clinical pathology

Published: May 13, 2025

Current androgen receptor antagonists under investigation for resistant prostate cancer: progress and challenges.

Current androgen receptor antagonists under investigation for resistant prostate cancer: progress and challenges.

Journal: Expert review of anticancer therapy

Published: March 16, 2025

The value of molecular features in predicting efficacy of immuno-combinations in kidney cancer: just a drop in the ocean?

The value of molecular features in predicting efficacy of immuno-combinations in kidney cancer: just a drop in the ocean?

Journal: Expert review of molecular diagnostics

Published: March 11, 2025

The Prognostic Role of 68GA-PSMA-PET/CT in Metastatic Hormone-Sensitive Prostate Cancer: A Preliminary Analysis.

The Prognostic Role of 68GA-PSMA-PET/CT in Metastatic Hormone-Sensitive Prostate Cancer: A Preliminary Analysis.

Journal: Clinical genitourinary cancer

Published: March 09, 2025

Insights into the impact of chromosome 3p mutations in advanced renal cell carcinoma treated with immune-based combinations or targeted therapy: A single-center experience.

Insights into the impact of chromosome 3p mutations in advanced renal cell carcinoma treated with immune-based combinations or targeted therapy: A single-center experience.

Journal: Pathology, research and practice

Published: February 28, 2025

Dual-energy spectral CT in renal cell carcinoma: dawn of a brand-new era?

Dual-energy spectral CT in renal cell carcinoma: dawn of a brand-new era?

Journal: Expert review of molecular diagnostics

Published: February 14, 2025

18F-Fluorodeoxyglucose Uptake in PDGFRA-Mutant Gastrointestinal Stromal Tumors.

18F-Fluorodeoxyglucose Uptake in PDGFRA-Mutant Gastrointestinal Stromal Tumors.

Journal: JAMA network open

Published: January 24, 2025

State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes.

State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes.

Journal: Human vaccines & immunotherapeutics

Published: December 19, 2024

Showing 1-12 of 56

Last Updated: 09/26/2026